Reached key milestones in the ORCA-OL long-term exposure trial, including completion of enrollment and meeting the requirement of 300 participants receiving six months of cumulative cytisinicline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback